Table 4 BIA of peginterferon beta-1a in Italy from the NHS perspective
Costs | Year 1 | Year 2 | Year 3 | Cumulative |
|---|---|---|---|---|
Base scenario (without peg-IFNβ-1a) (€) | 321,530,021 | 339,658,686 | 357,787,352 | 1,018,976,059 |
Alternative scenario (with peg-IFNβ-1a) (€) | 321,118,561 | 338,559,367 | 356,201,191 | 1,015,879,119 |
Absolute impact(€) | −411,460 | −1,099,319 | −1,586,161 | −3,096,940 |
Relative impact (%) | −0.13% | −0.32% | −0.44% | −0.30% |